Thermo Fisher Scientific Inc 8-K, filed Mar 11, 2021
Thermo Fisher Scientific Inc. (TMO)
8-K
2021-03-11
For: 2021-03-11
View Original
Added on
April 07, 2026
About this 8-K
Thermo Fisher Scientific Inc filed this 8-K on March 11, 2021.
Items reported
- Item 7.01: Regulation FD disclosure
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 11, 2021
(Exact name of Registrant as specified in its Charter)
| (State of incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||||||||
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (781 ) 622-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. ☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
THERMO FISHER SCIENTIFIC INC.
Item 7.01 Regulation FD Disclosure
Thermo Fisher Scientific Inc. (the “Company”) has recently completed the repurchase of an additional $500 million of shares of the Company’s common stock, par value $1.00 per share, pursuant to its current authorization. This follows the previously disclosed $1.5 billion repurchase completed by the Company in January.
2
THERMO FISHER SCIENTIFIC INC.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| THERMO FISHER SCIENTIFIC INC. | |||||||||||
| Date: | March 11, 2021 | By: | /s/ Michael A. Boxer | ||||||||
| Michael A. Boxer | |||||||||||
| Senior Vice President and General Counsel | |||||||||||
3